دورية أكاديمية
Comparative serum estradiol profiles from a new once-a-week transdermal estradiol patch and a twice-a-week transdermal estradiol patch.
العنوان: | Comparative serum estradiol profiles from a new once-a-week transdermal estradiol patch and a twice-a-week transdermal estradiol patch. |
---|---|
المؤلفون: | Harrison LI; Department of Pharmacokinetics and Drug Metabolism, 3M Pharmaceuticals, St. Paul, Minnesota 55144, USA., Riedel DJ, Chang SF, Jacobson JP, Sellers JA, Kanniainen CM, Crowley JK, Hinderling PH |
المصدر: | Therapeutic drug monitoring [Ther Drug Monit] 1997 Feb; Vol. 19 (1), pp. 37-42. |
نوع المنشور: | Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
اللغة: | English |
بيانات الدورية: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print Cited Medium: Print ISSN: 0163-4356 (Print) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Hagerstown, MD : Lippincott Williams & Wilkins Original Publication: [New York] Raven Press. |
مواضيع طبية MeSH: | Estradiol/*blood, Administration, Cutaneous ; Aged ; Delayed-Action Preparations ; Estradiol/administration & dosage ; Female ; Humans ; Middle Aged |
مستخلص: | Two identical open-label, randomized crossover studies were conducted to compare serum estradiol profiles from the new 12.5- and 25-cm2 once-a-week adhesive patches with those from the 10- and 20-cm2 commercially available twice-a-week Estraderm patches when applied as directed during a 1-week patch-wear period. Both studies were conducted in healthy postmenopausal women; serum estradiol levels were determined by gas chromatography/mass spectroscopy (GC/MS). Although both sizes of both patch treatments produced mean serum estradiol levels in the therapeutic range, the once-a-week patch provided more constant mean levels, avoiding large peak-to-trough fluctuations. As expected, the differences in mean serum estradiol concentrations between the two patch treatments occurred during the second application of the twice-a-week patch. Based on these results, the once-a-week drug in adhesive patch appears to be an acceptable means of hormone replacement therapy. |
المشرفين على المادة: | 0 (Delayed-Action Preparations) 4TI98Z838E (Estradiol) |
تواريخ الأحداث: | Date Created: 19970201 Date Completed: 19970417 Latest Revision: 20190905 |
رمز التحديث: | 20240627 |
DOI: | 10.1097/00007691-199702000-00006 |
PMID: | 9029744 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!